Skip to main content
Clinical Trials/NCT06755905
NCT06755905
Completed
Not Applicable

Application Value of Indocyanine Green Lymphography in Management of Microcystic Lymphatic Malformation of the Tongue

Nanjing Children's Hospital1 site in 1 country42 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lymphatic Malformation
Sponsor
Nanjing Children's Hospital
Enrollment
42
Locations
1
Primary Endpoint
Cured (Reduction in dimension greater than 90%)
Status
Completed
Last Updated
last year

Overview

Brief Summary

To elucidate the application of indocyanine green (ICG) fluorescence angiography in the treatment of childhood tongue cLM (clinically localized malignancy, presumed context here), providing a clearer scientific basis for subsequent targeted interventions.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
December 15, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Nanjing Children's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Tao Han

Clinical Professor

Nanjing Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • No previous intervention
  • more than 6 months post-treatment follow-up
  • Stage I or Stage IIa

Exclusion Criteria

  • History of iodine allergy
  • Syndromic cLM
  • Severe liver and kidney dysfunction

Outcomes

Primary Outcomes

Cured (Reduction in dimension greater than 90%)

Time Frame: From enrollment to the end of treatment at 12 weeks

Reduction in dimension greater than 90%

Study Sites (1)

Loading locations...

Similar Trials